Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nasal Breathing Performance in Elite Athletes
NCT06480071Completed
- Sponsor
- Sahlgrenska University Hospital
- Start
- Jan 2022
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of Mucinex Full Force Nasal Spray in nasal congestion (3 arms), sponsored by Sahlgrenska University Hospital. Primary endpoints: Maximal Oxygen Uptake, Blood Lactate Concentration and 1 more. Started Jan 2022; status: completed.
02
Drugs
Mucinex Full Force Nasal Spray
03
Conditions
nasal congestion
Beyond the preview
Go deeper on NCT06480071.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06480071.